BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu L, Zou J, Zhao Y, Jiang X, Wang Y, Wang X, Chen B. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway. J Exp Clin Cancer Res 2018;37:123. [PMID: 29940998 DOI: 10.1186/s13046-018-0798-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Wang C, Jin Y, Cai Y, Yao J, Meng Q, Wu J, Wang H, Sun H, Liu M. Anti-Postmenopausal osteoporosis effects of Isopsoralen: A bioinformatics-integrated experimental study. Phytother Res 2022. [PMID: 36123318 DOI: 10.1002/ptr.7609] [Reference Citation Analysis]
2 Qu C, Wang C, Li H, Li Y, Han C, Tao X, Guan X, Zhang Y, Chen M, Liu J, Zou W. Estrogen receptor variant ER-α36 facilitates estrogen signaling via EGFR in glioblastoma. Cell Biol Int 2022. [PMID: 35930599 DOI: 10.1002/cbin.11877] [Reference Citation Analysis]
3 Lu Z, Zhang A, Wang J, Han K, Gao H. Estrogen alleviates post-traumatic osteoarthritis progression and decreases p-EGFR levels in female mouse cartilage. BMC Musculoskelet Disord 2022;23:685. [PMID: 35854298 DOI: 10.1186/s12891-022-05608-y] [Reference Citation Analysis]
4 Li K, Zong D, Sun J, Chen D, Ma M, Jia L. Rewiring of the Endocrine Network in Triple-Negative Breast Cancer. Front Oncol 2022;12:830894. [DOI: 10.3389/fonc.2022.830894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Berkel C, Cacan E. Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer. Life Sci 2021;286:120029. [PMID: 34634322 DOI: 10.1016/j.lfs.2021.120029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Muscella A, Stefàno E, Calabriso N, De Pascali SA, Fanizzi FP, Marsigliante S. Role of epidermal growth factor receptor signaling in a Pt(II)-resistant human breast cancer cell line. Biochem Pharmacol 2021;192:114702. [PMID: 34324869 DOI: 10.1016/j.bcp.2021.114702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang S, Wei H, Huang Z, Wang X, Shen R, Wu Z, Lin J. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma. Acta Biochim Biophys Sin (Shanghai) 2021;53:317-24. [PMID: 33432347 DOI: 10.1093/abbs/gmaa177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Thiebaut C, Konan HP, Guerquin MJ, Chesnel A, Livera G, Le Romancer M, Dumond H. The Role of ERα36 in Development and Tumor Malignancy. Int J Mol Sci 2020;21:E4116. [PMID: 32526980 DOI: 10.3390/ijms21114116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
9 Urra FA, Araya-Maturana R. Putting the brakes on tumorigenesis with snake venom toxins: New molecular insights for cancer drug discovery. Semin Cancer Biol 2020:S1044-579X(20)30102-4. [PMID: 32428714 DOI: 10.1016/j.semcancer.2020.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
10 Bailly C. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma. Chem Biol Interact 2020;325:109124. [PMID: 32437694 DOI: 10.1016/j.cbi.2020.109124] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
11 Zhu X, Feng J, Fu W, Shu X, Wan X, Liu J. Effects of cisplatin on the proliferation, invasion and apoptosis of breast cancer cells following β‑catenin silencing. Int J Mol Med 2020;45:1838-50. [PMID: 32186756 DOI: 10.3892/ijmm.2020.4543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Liu D, Zhou K. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction. Clinical Breast Cancer 2020;20:41-50.e8. [DOI: 10.1016/j.clbc.2019.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Wang Y, Li K, Han S, Tian YH, Hu PC, Xu XL, He YQ, Pan WT, Gao Y, Zhang Z, Zhang JW, Wei L. Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer. Cancer Med 2019;8:1679-93. [PMID: 30806044 DOI: 10.1002/cam4.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]